Yuwen Wang

机构：Qiqihar University · ORCID：0009-0006-9405-6276

发表论文 99 篇 · 总被引 1496 次 · h-index 21

代表论文

• Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• Insight into the unique role of silver single-atom in atomic-thickness ZnIn2S4/g-C3N4 Van der Waals heterojunction for photocatalytic hydrogen evolution (2024 · Journal of Colloid and Interface Science · 被引 20)
• Antioxidant and hepatic fibrosis-alleviating effects of selenium-modified Bletilla striata polysaccharide (2025 · International Journal of Biological Macromolecules · 被引 19)
• Innate immune responsive inflammation in development of progressive myopia (2024 · Eye · 被引 17)
• Atomic level dispersed nickel coupled with silver nanoparticle to boost the efficiency of CO2 conversion to CO via spin electrons regulation (2024 · Applied Catalysis B: Environmental · 被引 16)
• Abundant interfacial and intrinsic oxygen vacancies enabling small nickel/ceria nanocrystal efficient CO2 methanation (2024 · Journal of Catalysis · 被引 13)